These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 561244)

  • 21. Endotoxin and coagulopathic disorders after ascitic fluid infusion.
    Fumarola D
    Mayo Clin Proc; 1979 Dec; 54(12):815. PubMed ID: 513848
    [No Abstract]   [Full Text] [Related]  

  • 22. [The role of middle molecules in the occurrence of a hyperthermic reaction during the reinfusion of ascitic fluid in patients with liver cirrhosis].
    Korotkiĭ VN; Pokrasen NM; Gaevskaia VA; Liakhov NP
    Klin Khir (1962); 1989; (9):62. PubMed ID: 2593531
    [No Abstract]   [Full Text] [Related]  

  • 23. Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis.
    Francés R; González-Navajas JM; Zapater P; Muñoz C; Caño R; Pascual S; Márquez D; Santana F; Pérez-Mateo M; Such J
    J Clin Immunol; 2007 Jul; 27(4):438-44. PubMed ID: 17404822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enterobacteria and endotoxins in abdominal surgical pathology. Critical review and clinico-experimental studies].
    Fumarola D; Fransvea P; Telesforo P; Pasquetto N; Mazzone A; Miragliotta G
    Minerva Chir; 1975 Oct; 30(20):1040-8. PubMed ID: 1207932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of fibrinogen or fibrin degradation products in the ascitic fluid].
    Kolodie L; Detante J; Rachail M
    Nouv Presse Med; 1978 Feb; 7(8):665. PubMed ID: 417295
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl(4)-induced cirrhosis.
    Bhimani EK; Serracino-Inglott F; Sarela AI; Batten JJ; Mathie RT
    J Surg Res; 2003 Jul; 113(1):172-8. PubMed ID: 12943827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Glucose and insulin in the blood and ascitic fluid after oral administration of glucose in hepatic cirrhosis].
    Greco AV; Rebuzzi AG; Altomonte L; Manna R; Ghirlanda G
    Minerva Dietol Gastroenterol; 1982; 28(2):133-6. PubMed ID: 7048132
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation.
    Lee FY; Lu RH; Tsai YT; Lin HC; Hou MC; Li CP; Liao TM; Lin LF; Wang SS; Lee SD
    Scand J Gastroenterol; 1996 May; 31(5):500-5. PubMed ID: 8734349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and ascitic fluid magnesium in bilharzial (schistosomal) hepatic fibrosis.
    Ghanem MH; Guirgis FK; el-Sawy M
    J Trop Med Hyg; 1970 Oct; 73(10):237-9. PubMed ID: 5478038
    [No Abstract]   [Full Text] [Related]  

  • 30. Alterations in the carbohydrate moiety of alpha-1-acid glycoprotein purified from human cirrhotic ascitic fluid.
    Biou D; Konan D; Féger J; Agneray J; Leroy Y; Cardon P; Fournet B; Durand G
    Biochim Biophys Acta; 1987 Jul; 913(3):308-12. PubMed ID: 3297164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative characteristics of the lipid composition of lipoproteins of the blood plasma and ascitic fluid in liver cirrhosis].
    Kosukhin AB; Riudiger PE; Akhmetova BS; Andreev GN
    Patol Fiziol Eksp Ter; 1989; (2):13-7. PubMed ID: 2755715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal and opsonic activity of ascitic fluid from cirrhotic and noncirrhotic patients.
    Akalin HE; Laleli Y; Telatar H
    J Infect Dis; 1983 Jun; 147(6):1011-7. PubMed ID: 6854061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous endotoxemia in patients with liver cirrhosis--a quantitative analysis of endotoxin in portal and peripheral blood.
    Tachiyama G; Sakon M; Kambayashi J; Iijima S; Tsujinaka T; Mori T
    Jpn J Surg; 1988 Jul; 18(4):403-8. PubMed ID: 3172582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
    Chen TA; Tsao YC; Chen A; Lo GH; Lin CK; Yu HC; Cheng LC; Hsu PI; Tsai WL
    Scand J Gastroenterol; 2009; 44(5):619-25. PubMed ID: 19191184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia.
    Guarner C; Soriano G; Tomas A; Bulbena O; Novella MT; Balanzo J; Vilardell F; Mourelle M; Moncada S
    Hepatology; 1993 Nov; 18(5):1139-43. PubMed ID: 8225220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The distribution of ammonium nitrogen in venous blood, ascites, and cerebrospinal fluid in cases of hepatic cirrhosis.
    Ciplea A; Baltă N; Stancu C; Drăgulescu N
    Rev Roum Physiol; 1970; 7(2):163-70. PubMed ID: 5492066
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diffusion of gentamicin into infected ascitic fluid in cirrhotic patients].
    Latrive JP; Messerschmitt C; Preux MC
    Gastroenterol Clin Biol; 1984 Oct; 8(10):767-8. PubMed ID: 6526231
    [No Abstract]   [Full Text] [Related]  

  • 38. Properties of 1 -acid glycoprotein from ascitic fluids.
    Horikawa M; Kurokawa M; Hotta K
    Kitasato Arch Exp Med; 1970 Jun; 43(1):1-9. PubMed ID: 4998553
    [No Abstract]   [Full Text] [Related]  

  • 39. Endotoxin measures in patients' sample: how valid are the results?
    Stadlbauer V; Davies NA; Wright G; Jalan R
    J Hepatol; 2007 Nov; 47(5):726-7; author reply 727-3. PubMed ID: 17850915
    [No Abstract]   [Full Text] [Related]  

  • 40. [Plasma endotoxin measured by the combination of new perchloric acid pretreatment method and endotoxin specific assay in liver cirrhosis].
    Narita T
    Nihon Shokakibyo Gakkai Zasshi; 1992 May; 89(5):1252-9. PubMed ID: 1320142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.